| abstract |
Abstract This disclosure relates to uridine diphosphate (UDP) derivatives, compositions comprising therapeutically effective amounts of those UDP derivatives or salts thereof, and methods of using those derivatives, salts or compositions in treating disorders that are responsive to ligands, such as agonists, of P2Y6 receptor in neuronal disorders, including neurodegenerative disorders (e.g., Alzheimer's disease), traumatic central nervous system (CNS) injury, as well as in pain. Z Z R1TILN.X....,A R11,NA-1...A .0 N W 0 0 OH OH OH OH Date Recue/Date Received 2020-10-01 |